Antileukemic immunity associated with antineutrophil antibody production after allogeneic hematopoietic SCT for myeloid/NK-cell precursor acute leukemia.
Suzuki
Hi
H
Suzuki
T
T
Kamijo
A
A
Oota
S
S
Sato
H
H
Hangaishi
A
A
Takahashi
T
T
Kanda
Y
Y
Motokura
T
T
Chiba
S
S
Kurokawa
M
M
D000328:Adult; D001323:Autoantibodies / Q000276:immunology; D003907:Dexamethasone / Q000627:therapeutic use; D020544:Graft vs Leukemia Effect / Q000276:immunology*; D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects*; D006801:Humans; D007694:Killer Cells, Natural / Q000276:immunology*; D007951:Leukemia, Myeloid / Q000276:immunology* / Q000628:therapy; D017254:Leukemic Infiltration / Q000276:immunology; D008297:Male; D009503:Neutropenia / Q000188:drug therapy / Q000209:etiology / Q000276:immunology; D009504:Neutrophils / Q000276:immunology*; D011239:Prednisolone / Q000627:therapeutic use; D012008:Recurrence
D001323:Autoantibodies; D003907:Dexamethasone; D011239:Prednisolone